Overview
Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by keratinocyte hyperproliferation, resulting in well-demarcated erythematous plaques with silvery scales. Affecting approximately 2-3% of the global population, psoriasis is now understood as a systemic inflammatory condition rather than merely a skin disease — it associates strongly with cardiovascular disease, type 2 diabetes, depression, and inflammatory bowel disease, sharing inflammatory pathways and microbiome signatures with all of these conditions.
The IL-17/IL-23 axis is the central immunological driver, with Th17 cells producing IL-17A/F that stimulates keratinocyte proliferation and recruits neutrophils to the epidermis. What WikiBiome adds to this picture is the recognition that the gut microbiome regulates Th17/Treg balance, that metals modulate immune polarization, and that the gut-skin axis creates a systemic inflammatory circuit.
The Gut-Skin Axis
Psoriasis demonstrates a robust gut-skin axis — a bidirectional communication pathway linking intestinal and cutaneous inflammation:
Gut to Skin
- Gut dysbiosis reduces SCFA production and butyrate-mediated Treg induction
- Impaired barrier allows LPS and microbial antigens to reach systemic circulation
- Systemic IL-17/IL-23 activation — gut-primed Th17 cells migrate to skin via CCR6/CCL20 homing
- Keratinocyte activation — IL-17A drives keratinocyte proliferation, antimicrobial peptide production, and neutrophil recruitment
- Plaque formation — the visible manifestation of systemic immune dysregulation
Skin to Gut
- Psoriatic skin lesions produce systemic cytokines (TNF-alpha, IL-6) that alter gut permeability
- Biologic therapies targeting TNF-alpha or IL-17 improve both skin and gut symptoms, confirming shared pathways
Microbiome Associations
Gut Microbiome
Psoriasis patients show gut microbiome changes that overlap with other inflammatory conditions:
- Depleted: faecalibacterium prausnitzii, bifidobacterium, Akkermansia — anti-inflammatory, SCFA-producing taxa
- Enriched: escherichia coli, certain bacteroides species, Proteobacteria
- Functional: Reduced butyrate production, increased LPS biosynthesis, altered tryptophan metabolism
The depletion of F. prausnitzii is shared with inflammatory bowel disease, depression, and cardiovascular disease — suggesting a common anti-inflammatory "anchor species" whose loss enables Th17-dominant inflammation.
Skin Microbiome
Psoriatic plaques have a distinct cutaneous microbiome:
- Enriched: streptococcus, staphylococcus aureus, Corynebacterium
- Depleted: Cutibacterium (formerly Propionibacterium) acnes — a paradox since C. acnes is associated with acne but appears protective in psoriasis
- Streptococcal throat infections are well-known triggers of guttate psoriasis, linking the pharyngeal microbiome to skin flares
Virome
Blood DNA virome analysis reveals altered viral signatures in autoimmune diseases including psoriasis [1], suggesting viral components of the microbiome may contribute to immune dysregulation.
Metal Associations
Nickel and the Koebner Phenomenon
The Koebner phenomenon — development of psoriatic lesions at sites of skin trauma — has a metal-immune dimension:
- Nickel contact can trigger psoriatic flares in sensitized individuals
- Nickel directly activates tlr4 (human-specific), which feeds into the NF-kB → IL-23 → IL-17 cascade
- Nickel allergy prevalence is elevated in psoriasis patients compared to controls
- Occupational nickel exposure may be an underrecognized trigger
Copper/Zinc Ratio
- Copper is often elevated in psoriasis, reflecting systemic inflammation (ceruloplasmin is an acute-phase reactant)
- Zinc is frequently depleted; zinc deficiency impairs keratinocyte differentiation and wound healing
- The Cu/Zn ratio is elevated, similar to the pattern in schizophrenia, bipolar disorder, and other inflammatory conditions
- Zinc is a cofactor for the nuclear hormone receptors (VDR, RAR) targeted by psoriasis treatments (vitamin D analogs, retinoids)
Iron
- Iron dysregulation with elevated ferritin (acute-phase response) is common
- The Th17-dominant immune state can drive hepcidin production, creating functional iron deficiency
- This mirrors the nutritional immunity response seen in infectious conditions
Associated Conditions
Psoriasis has extensive comorbidity that shares microbiome and metallomic features:
| Condition | Shared Pathway | Prevalence in Psoriasis |
|---|---|---|
| Psoriatic arthritis | IL-17/IL-23 axis | 30% of psoriasis patients |
| cardiovascular disease | Systemic inflammation, Faecalibacterium depletion | 1.5-2x risk |
| type 2 diabetes | Insulin resistance, gut dysbiosis | 2x risk |
| depression | Gut-brain axis, tryptophan diversion | 20-30% comorbidity |
| inflammatory bowel disease | Shared Th17 pathway, Faecalibacterium loss | 3-4x risk |
Open Questions
- Can gut microbiome restoration reduce psoriasis severity (FMT or targeted probiotics)?
- Does nickel avoidance improve outcomes in nickel-sensitized psoriasis patients?
- Is the Cu/Zn ratio a useful biomarker for psoriasis disease activity?
- Can zinc supplementation enhance response to biologic therapy?
- Does the blood virome normalize with effective psoriasis treatment?
Key Studies
- [2] — host-microbiome interactions across immune-mediated conditions
- [1] — virome alterations in autoimmune disease
Cross-References
- inflammatory bowel disease — shared Th17 pathway and taxa depletion
- cardiovascular disease — shared systemic inflammation
- nickel allergy — TLR4-mediated immune trigger
- toll like receptors — innate immune activation
- butyrate — depleted anti-inflammatory SCFA
- immune balance — Th17/Treg dysregulation